Vet-Stem Secures Exclusive Veterinary Rights for Fat Derived Stem Cells
Vet-Stem, Inc. has announced that a license agreement with the University of California has been completed which secures Vet-Stem's exclusive rights to stem cells derived from fat for veterinary use.
The veterinary rights for stem cells from fat were originally shared between the University of California and Pittsburg University.
A license agreement with Artecel Inc, the licensee of Pittsburg University, provided Vet-Stem with the original license for use of the regenerative cells.
With the addition of the license from the University of California, Vet-Stem now has exclusive rights for veterinary use which improves the company's intellectual property position in this rapidly developing field.
"Intellectual property rights can be confusing in a rapidly developing market with evolving technology," said Bob Harman, DVM, MPVM, CEO of Vet-Stem.
"We needed to do everything possible to protect the market that we are creating in regenerative veterinary medicine and to ensure that the value of the company is optimized."
"The value of this technology has increased greatly since the founding of the company in 2002 as the business model, therapeutic activity of the cells, and ease of tissue collection have all been demonstrated."
"We did not want to create a market and provide an opportunity for a potential competitor."
The company currently offers stem cell services to veterinarians for treatment of lameness in horses.
New uses of regenerative cells are in development for diseases in dogs and horses that often times have few other treatment options.
The combination of expanded uses of the cells and a growing network of veterinarians using regenerative cell therapy has created the need to secure exclusive rights.
Vet-Stem regenerative cells include stem cells as well as cells that produce growth factors, blood vessels, and assist with regeneration of tissues.
These cells are obtained from processing of a small fat sample from the injured animal.
The regenerative cells are then shipped back to the veterinarian for injection directly into the injured site or tissue.